Corcept Therapeutics
CORT | NASDAQ
$80.35
-$0.77 (-0.95%)
Nov 2, 2026, 3:45 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 42.99M | -31.76M | 98.17M | 19.36M | 35.15M | 20.55M | 30.39M | 46.69M | 35.12M | 27.76M | 31.36M | 31.38M | 27.53M | 15.88M | 16.6M | 34.61M | 27.41M | 22.8M | 32.05M | 30.47M | 26.52M | 23.47M |
Depreciation & Amortization | 863K | 598K | 482K | 477K | 469K | 462K | 460K | 499K | 257K | 179K | 630K | 289K | 823K | 859K | 747K | 752K | 668K | 802K | 797K | 771K | 756K | 743K |
Stock-Based Compensation | 29.42M | 23.04M | -63.73M | n/a | 19.02M | 21.83M | 16.8M | n/a | n/a | 13.25M | 13.07M | 12.88M | 11.86M | 11.14M | 10.52M | 10.55M | 10.61M | 10.76M | 10.81M | 10.95M | 11.07M | 10.1M |
Other Working Capital | 13.58M | -1.39M | -14.18M | 1.43M | 20.53M | -28M | 15.55M | 33M | -5.32M | 2.86M | -27.12M | 14.01M | 16.22M | 7.9M | 22M | -2.65M | -9.04M | 7.18M | 2.14M | 1.82M | 3.66M | -6.09M |
Other Non-Cash Items | 4.17M | -3.95M | 1.38M | 22.18M | -1.31M | -1.69M | -1.83M | 13.76M | 12.49M | -2.86M | -3.2M | -2.75M | -1.68M | -1.5M | -738K | 251K | 764K | 1.11M | 1.29M | 1.33M | 1.28M | 1.19M |
Deferred Income Tax | 2.88M | -13.11M | n/a | 9.11M | -17.76M | -13.71M | -3.86M | -15.21M | -13.96M | -7.16M | -3.67M | -8.86M | -10.24M | -6.73M | -4.47M | -8.87M | -10.63M | -9.94M | 2.3M | 4.11M | 3.3M | -5.36M |
Change in Working Capital | -46.77M | 8.41M | 2.14M | 3.35M | 8.37M | -22.31M | 17.35M | 28.09M | 7.28M | -7.41M | -32.3M | 19.98M | 13.99M | 6.31M | 10.72M | -3.64M | -10.78M | 9.72M | 2.18M | 1.07M | 1.42M | -4.72M |
Operating Cash Flow | 33.54M | -16.77M | 38.45M | 54.48M | 43.94M | 5.13M | 59.3M | 73.83M | 41.18M | 23.76M | 5.89M | 52.91M | 42.29M | 25.96M | 33.39M | 33.65M | 18.04M | 35.25M | 49.43M | 48.7M | 44.34M | 25.42M |
Capital Expenditures | -2.53M | -201K | -50K | n/a | -57K | -104K | -121K | -1.64M | -416K | n/a | n/a | -37K | -102K | n/a | -31K | -351K | -19K | -12K | -65K | -159K | -119K | -126K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -88.96M | -52.33M | -143.83M | -37.36M | -23.27M | -115.15M | -144.57M | -223.13M | -142.73M | -77.88M | -29.9M | -210.03M | -88.82M | n/a | -96.64M | -78.85M | -86.96M | -92.61M | n/a | -89.54M | -95.88M | -127.39M |
Sales Maturities Of Investments | 62.24M | 57.07M | 132.04M | 52M | 93.46M | 112.08M | 80.33M | 180.73M | 82.95M | 68.86M | 47M | 100.5M | 64.82M | 207.48M | 79.43M | 74.41M | 45.18M | 42.13M | 140.54M | 63.89M | 120.74M | 124.23M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -29.24M | 4.54M | -11.84M | 14.65M | 70.13M | -3.17M | -64.36M | -44.04M | -60.19M | -9.01M | 17.1M | -109.57M | -24.1M | 207.48M | -17.24M | -4.79M | -41.8M | -50.5M | 140.47M | -25.8M | 24.74M | -3.28M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -11.46M | -5.76M | -36.54M | -42.46M | -103.02M | n/a | n/a | -11.71M | -3.48M | n/a | n/a | n/a | -145.43M | n/a | n/a | n/a | n/a | n/a | -207.5M | -25.77M | -29.17M | -33.54M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 10K | 5.32M | -8.15M | -12.43M | -39.8M | -4.56M | -11.65M | -1.91M | -543K | 766K | -3.92M | -1.82M | 181K | -61K | -13.96M | -2.76M | -506K | 531K | 2.13M | 3.14M | -12.41M |
Financial Cash Flow | -2.04M | 760K | -31.22M | -46.41M | -102.93M | -39.8M | -4.56M | -21.09M | -2.15M | -543K | 766K | -3.92M | -145.75M | 181K | -61K | -13.96M | -2.76M | -506K | -206.97M | -23.64M | -26.03M | -45.95M |
Net Cash Flow | 2.3M | -11.76M | -4.64M | 22.39M | 12.93M | -37.85M | -9.62M | 8.7M | -21.16M | 14.2M | 23.75M | -60.58M | -127.57M | 233.61M | 16.09M | 14.9M | -26.52M | -15.76M | -17.07M | -742K | 43.05M | -23.81M |
Free Cash Flow | 31.02M | -16.97M | 38.4M | 54.48M | 43.88M | 5.02M | 59.18M | 72.19M | 40.77M | 23.76M | 5.89M | 52.87M | 42.18M | 25.96M | 33.36M | 33.3M | 18.02M | 35.24M | 49.36M | 48.55M | 44.22M | 25.3M |
Adj. Free Cash Flow | 1.6M | -40.02M | 102.13M | 54.48M | 24.86M | -16.81M | 42.38M | 72.19M | 40.77M | 10.51M | -7.18M | 40M | 30.33M | 14.82M | 22.84M | 22.74M | 7.42M | 24.47M | 38.55M | 37.59M | 33.15M | 15.2M |
Maintenance CapEx | -863K | -201K | n/a | n/a | n/a | -20.75K | n/a | -1.2M | -75.46K | n/a | n/a | n/a | -18.89K | n/a | -1.57K | -312.1K | n/a | n/a | n/a | -86.06K | -96.51K | -126K |
Growth CapEx | -1.67M | n/a | -50K | n/a | -57K | -83.25K | -121K | -435.6K | -340.54K | n/a | n/a | -37K | -83.11K | n/a | -29.43K | -38.9K | -19K | -12K | -65K | -72.94K | -22.49K | n/a |
Owner Earnings | 32.68M | -16.97M | 38.45M | 54.48M | 43.94M | 5.11M | 59.3M | 72.63M | 41.11M | 23.76M | 5.89M | 52.91M | 42.27M | 25.96M | 33.39M | 33.34M | 18.04M | 35.25M | 49.43M | 48.62M | 44.24M | 25.3M |
Add to Watchlist
Select watchlists to add or remove CORT